Clinical trial
Ambroxol as a Novel Disease Modifying Treatment for Parkinson's Disease Dementia
NCT02914366 is registered in ClinicalTrials.gov with London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ambroxol as a Novel Disease Modifying Treatment for Parkinson's Disease Dementia
- Lead sponsor
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- November 30, 2015
- Completion date
- December 31, 2025
- Enrollment
- 55 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
parkinson's disease dementia